The expression of MTH1, also known as NUDT1, is upregulated in multiple types of digestive tract tumors [3, 13], and high MTH1 expression promotes the survival of tumor cells but not normal cells [4, 14], making MTH1 a potential target for cancer treatment [15–17]. Here, NUDT1 is linked to neoplasm.